CEO Jeffrey K. Norman of St. Joseph Medical Center in Maryland Resigns Amid Stent Controversy

Jeffrey Norman, CEO of St. Joseph Medical Center in Towson, Md., announced his resignation “without explanation,” effective Aug. 22, according to a Baltimore Sun report.

Advertisement

Mr. Norman was appointed CEO in the middle of a “management shake-up” in 2009 after Mark Midei, MD, a cardiologist at the hospital, left amid allegations he had performed numerous unnecessary stent procedures.

St. Joseph Medical Center has since been mired with federal investigations and numerous medical malpractice lawsuits over the alleged unnecessary stent procedures. Last year, the hospital agreed to pay the federal government $22 million to settle False Claims Act allegations involving its relationship with Dr. Midei. The settlement also resolved Stark allegations involving alleged kickbacks to MidAtlantic Cardiovascular Associates — where Dr. Midei was a one-time partner — for the practice’s referrals to the hospital.

Mr. Norma’s resignation comes shortly after the Maryland Board of Physicians revoked Dr. Midei’s license, writing in an 11-page order that his violations were “repeated and serious.”

Hospital officials said they would begin a search for Mr. Norman’s successor immediately, according to the report.

Read the Baltimore Sun report about Jeffrey Norman.

Related Articles on St. Joseph Medical Center:

Former Cardiologist From Maryland’s St. Joseph Medical Center Loses Medical License Over Unnecessary Stent Allegations
Maryland Cardiologist Accused of Performing Unnecessary Stents Sues Hospital
Maryland’s St. Joseph Medical Center to Pay $22M to Settle False Claims, Kickback Allegations

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Executive Moves

  • Optum Rx has named Jon Bosland as its next chief financial officer. “The PBM space is at an inflection point…

  • Several women have recently stepped into new executive roles at hospitals and health systems — including through promotions, new appointments…

Advertisement

Comments are closed.